FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 329

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRRX Nasdaq DURECT Corporation 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DTIL Nasdaq Precision BioSciences, Inc. 2836
DVAX Nasdaq Dynavax Technologies Corporation 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EDSA Nasdaq Edesa Biotech, Inc. 2836
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2836
ELEV Nasdaq Elevation Oncology, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ELVN Nasdaq Enliven Therapeutics, Inc. 2836
ENTA Nasdaq Enanta Pharmaceuticals, Inc. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
ENVB Nasdaq Enveric Biosciences, Inc. 2836
EPIX Nasdaq ESSA Pharma Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Ernexa Therapeutics Inc. 2836
ESPR Nasdaq Esperion Therapeutics, Inc. 2836
ETNB Nasdaq 89bio, Inc. 2836
EXEL Nasdaq Exelixis, Inc. 2836
EXOZ Nasdaq eXoZymes, Inc. 2836
FBRX Nasdaq Forte Biosciences, Inc. 2836
FDMT Nasdaq 4D Molecular Therapeutics, Inc. 2836
FENC Nasdaq Fennec Pharmaceuticals Inc. 2836
FHTX Nasdaq Foghorn Therapeutics Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GHRS Nasdaq GH Research PLC 2836
GLMD Nasdaq Galmed Pharmaceuticals Ltd. 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GMAB Nasdaq Genmab A/S 2836
GMED New York Globus Medical, Inc. 2836
GNFT Nasdaq Genfit S.A. 2836
GNLX Nasdaq Genelux Corporation 2836
GNPX Nasdaq Genprex, Inc. 2836
GRFS Nasdaq Grifols, S.A. 2836
GTBP Nasdaq GT Biopharma, Inc. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HOOK Nasdaq HOOKIPA Pharma Inc. 2836
HOTH Nasdaq Hoth Therapeutics, Inc. 2836
HRGN Over the counter Harvard Apparatus Regenerative Technolog 2836
HURA Nasdaq TuHURA Biosciences, Inc. 2836
IBIO Nasdaq iBio, Inc. 2836
IBO NYSE American Impact BioMedical Inc. 2836
IBRX Nasdaq ImmunityBio, Inc. 2836
IFRX Nasdaq InflaRx N.V. 2836
IGMS Nasdaq IGM Biosciences, Inc. 2836
IKT Nasdaq Inhibikase Therapeutics, Inc. 2836
IMAB Nasdaq I-Mab 2836
IMCR Nasdaq Immunocore Holdings plc 2836
Results 100 through 150 of 329